Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter:
“Congrats Neeraj Agarwal on yet another stellar achievement! And for lifting everyone around you!
Huntsman Cancer Institute is so lucky to have you.”
Quoting Sumanta Pal’s post”
“After all these years of knowing him, he never ceases to amaze. Whether its mentoring stellar residents/fellows/faculty (Umang Swami, Andy Hahn, Georges Gebrael et al), leading practice changing trials in prostate cancer or driving collaborative research (exemplified by his R01 w Adriana M Coletta, Huntsman Cancer Institute), he just does it all. Congrats on yet another major achievement!”
Source: Shilpa Gupta/X and Sumanta Pal/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.
Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023